BIOLASE, Inc. Gains 249.57%
Wed, Apr 08, 2020 at 05:30 PM
BIOLASE, Inc. (BIOL:NASDAQ) rocketted at $0.8, representing a gain of 249.6%. The stock appeared on our News Catalysts scanner on Wed 08 Apr 20 at 05:13 PM in the 'PATNERSHIP' category.
About BIOLASE, Inc. (BIOL:NASDAQ)
Biolase Inc is a medical device company that develops, manufactures, and markets lasers in dentistry and medicine and also markets and distributes dental imaging equipment.
Top 10 Gainers:
- BIOLASE, Inc. (BIOL:NASDAQ), 249.57%
- Moleculin Biotech, Inc. (MBRX:NASDAQ), 125.7%
- Ellington Financial Inc. (EFC:NYSE), 74.71%
- Moxian, Inc. (MOXC:NASDAQ), 64.15%
- Intelsat S.A. (I:NYSE), 57.14%
- Exantas Capital Corp. (XAN:NYSE), 51.78%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 50.85%
- Ellington Residential Mortgage REIT (EARN:NYSE), 50.37%
- New York Mortgage Trust, Inc. (NYMT:NASDAQ), 49.25%
- Forestar Group Inc. (FOR:NYSE), 47.06%